478 related articles for article (PubMed ID: 21600301)
1. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
Betz UA
Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
[TBL] [Abstract][Full Text] [Related]
2. An unbalanced portfolio.
Federsel HJ
Drug News Perspect; 2009 Jun; 22(5):287-92. PubMed ID: 19609466
[TBL] [Abstract][Full Text] [Related]
3. Does process excellence handcuff drug development?
Koenig J
Drug Discov Today; 2011 May; 16(9-10):377-81. PubMed ID: 21349347
[TBL] [Abstract][Full Text] [Related]
4. To measure is to know: an approach to CADD performance metrics.
Loughney D; Claus BL; Johnson SR
Drug Discov Today; 2011 Jul; 16(13-14):548-54. PubMed ID: 21605697
[TBL] [Abstract][Full Text] [Related]
5. Lessons learned from candidate drug attrition.
Empfield JR; Leeson PD
IDrugs; 2010 Dec; 13(12):869-73. PubMed ID: 21154145
[TBL] [Abstract][Full Text] [Related]
6. What is the most important approach in current drug discovery: doing the right things or doing things right?
Elebring T; Gill A; Plowright AT
Drug Discov Today; 2012 Nov; 17(21-22):1166-9. PubMed ID: 22569181
[TBL] [Abstract][Full Text] [Related]
7. Strategies for bringing drug delivery tools into discovery.
Kwong E; Higgins J; Templeton AC
Int J Pharm; 2011 Jun; 412(1-2):1-7. PubMed ID: 21421040
[TBL] [Abstract][Full Text] [Related]
8. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
Campbell JB
IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
[TBL] [Abstract][Full Text] [Related]
9. Research & market strategy: how choice of drug discovery approach can affect market position.
Sams-Dodd F
Drug Discov Today; 2007 Apr; 12(7-8):314-8. PubMed ID: 17395091
[TBL] [Abstract][Full Text] [Related]
10. Efficient and effective compound management to support lead optimization.
Johnson CW; Chatterjee M; Kubala S; Helm D; Houston J; Banks M
J Biomol Screen; 2009 Jun; 14(5):523-30. PubMed ID: 19483145
[TBL] [Abstract][Full Text] [Related]
11. [Biomarkers: "Found in translation"].
Lockhart BP; Walther B
Med Sci (Paris); 2009 Apr; 25(4):423-30. PubMed ID: 19409197
[TBL] [Abstract][Full Text] [Related]
12. An assessment of R&D productivity in the pharmaceutical industry.
Dimitri N
Trends Pharmacol Sci; 2011 Dec; 32(12):683-5. PubMed ID: 22030299
[TBL] [Abstract][Full Text] [Related]
13. Discontinued drugs in 2010: oncology drugs.
Williams R
Expert Opin Investig Drugs; 2011 Nov; 20(11):1479-96. PubMed ID: 21955127
[TBL] [Abstract][Full Text] [Related]
14. Re-engineering drug discovery and development.
FitzGerald GA
LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
[TBL] [Abstract][Full Text] [Related]
15. Compound management beyond efficiency.
Burr I; Winchester T; Keighley W; Sewing A
J Biomol Screen; 2009 Jun; 14(5):485-91. PubMed ID: 19502566
[TBL] [Abstract][Full Text] [Related]
16. [The discovery process in the pharmaceutical industry].
Scatton B
J Soc Biol; 2009; 203(3):249-69. PubMed ID: 19833071
[TBL] [Abstract][Full Text] [Related]
17. How should we support pharmaceutical innovation?
Grootendorst P
Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
[TBL] [Abstract][Full Text] [Related]
18. Drug development: from concept to marketing!
Tamimi NA; Ellis P
Nephron Clin Pract; 2009; 113(3):c125-31. PubMed ID: 19729922
[TBL] [Abstract][Full Text] [Related]
19. Synthetic therapeutic peptides: science and market.
Vlieghe P; Lisowski V; Martinez J; Khrestchatisky M
Drug Discov Today; 2010 Jan; 15(1-2):40-56. PubMed ID: 19879957
[TBL] [Abstract][Full Text] [Related]
20. The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery.
Thomas CE; Will Y
Expert Opin Drug Discov; 2012 Feb; 7(2):109-22. PubMed ID: 22468913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]